EP1417169 - SELECTIVE ESTROGEN RECEPTOR MODULATORS [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 03.11.2006 Database last updated on 08.10.2024 | Most recent event Tooltip | 25.07.2008 | Change - representative | published on 27.08.2008 [2008/35] | Applicant(s) | For all designated states Bristol-Myers Squibb Pharma Company P.O. Box 4000 Princeton NJ 08543-4000 / US | [N/P] |
Former [2004/20] | For all designated states Bristol-Myers Squibb Pharma Company PO Box 4000 Princeton, New Jesey 08543-4000 / US | Inventor(s) | 01 /
KALTENBACH, Robert 2004 Walmsley Drive Wilmington, DE 19808 / US | 02 /
ROBINSON, Simon P.O. Box 497 Stow, MA 01775 / US | 03 /
TRAINOR, George 9 Carillon Court Wilmington, DE 19803 / US | [2004/20] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [N/P] |
Former [2008/35] | Vossius & Partner Siebertstrasse 3 81675 München / DE | ||
Former [2004/20] | VOSSIUS & PARTNER Siebertstrasse 4 81675 München / DE | Application number, filing date | 02757058.9 | 09.08.2002 | [2004/20] | WO2002US25394 | Priority number, date | US20010311466P | 11.08.2001 Original published format: US 311466 P | [2004/20] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO03016270 | Date: | 27.02.2003 | Language: | EN | [2003/09] | Type: | A2 Application without search report | No.: | EP1417169 | Date: | 12.05.2004 | Language: | EN | The application published by WIPO in one of the EPO official languages on 27.02.2003 takes the place of the publication of the European patent application. | [2004/20] | Search report(s) | International search report - published on: | EP | 06.11.2003 | Classification | IPC: | C07C311/51, C07C69/587, C07C69/653, C07C57/48, C07C31/10, C07D311/58, C07D257/04, A61P19/10, A61P9/00, A61P13/00, A61P35/00, A61K31/192, A61K31/18, A61K31/352, A61K31/41 | [2004/20] | CPC: |
C07D257/04 (EP,US);
A61P1/00 (EP);
A61P13/00 (EP);
A61P13/08 (EP);
A61P15/00 (EP);
A61P19/10 (EP);
A61P25/28 (EP);
A61P3/10 (EP);
A61P35/00 (EP);
A61P43/00 (EP);
A61P5/30 (EP);
A61P9/00 (EP);
C07C255/34 (EP,US);
C07C311/51 (EP,US);
C07C51/487 (EP,US);
C07C57/50 (EP,US);
C07C59/54 (EP,US);
C07C59/72 (EP,US);
C07C69/618 (EP,US);
C07C69/734 (EP,US);
C07D277/80 (EP,US);
C07D311/58 (EP,US);
C07D333/34 (EP,US);
C07C2601/10 (EP,US);
| C-Set: |
C07C51/487, C07C59/54 (EP,US)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, SK, TR [2004/20] | Extension states | AL | 09.03.2004 | LT | 09.03.2004 | LV | 09.03.2004 | MK | 09.03.2004 | RO | 09.03.2004 | SI | 09.03.2004 | Title | German: | SELEKTIVE ÖSTROGENREZEPTORMODULATOREN | [2004/20] | English: | SELECTIVE ESTROGEN RECEPTOR MODULATORS | [2004/20] | French: | MODULATEURS SELECTIFS DE RECEPTEUR D'OESTROGENE | [2004/20] | Entry into regional phase | 09.03.2004 | National basic fee paid | 09.03.2004 | Designation fee(s) paid | 09.03.2004 | Examination fee paid | Examination procedure | 24.02.2003 | Request for preliminary examination filed International Preliminary Examining Authority: US | 11.02.2004 | Amendment by applicant (claims and/or description) | 09.03.2004 | Examination requested [2004/25] | 18.10.2006 | Application withdrawn by applicant [2006/49] | Fees paid | Renewal fee | 09.03.2004 | Renewal fee patent year 03 | 12.08.2005 | Renewal fee patent year 04 | 14.08.2006 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]US5681835 (WILLSON TIMOTHY MARK [US]) [X] 1-3,8-11,13-17 *compounds 6, 8 and 9*; column 22, line 66 - column 23, line 9 *; | [X]WO9908682 (UNIV DUKE [US]) [X] 1-3,8-11,13-17 *compounds GW 5638 and GW 7604*;; table I * * claim - *; | [X]US6005003 (NIQUE FRANCOIS [FR]) [X] 1-3,7,12-17 * column 3 * * column 6, line 55 - column 7, line 52 *; | [A]WO0126651 (ENDORECH INC [CA], et al) [A] 1-17*the whole document*; | [PX]WO0177055 (DU PONT PHARM CO [US]) [PX] 1-3,8-11,13-17 * page 12, lines 32-35 * * page 13, lines 6-27; example -; claim - *; | [PX]WO0177057 (DU PONT PHARM CO [US]) [PX] 1-3,8-11,13-17 *compounds of formula (I) in particular compounds 5 and 6*; page 23 - page 25; claim - *; | [X] - THOMAS S. SCANLAN, "Differential SERM activation of the estrogen receptors (ERalpha and ERbeta) at AP-1 sites", CHEMISTRY & BIOLOGY, (2001), vol. 8, no. 5, pages 427 - 436, XP002220838 [X] 1-3,8-11,13-17 * abstract * DOI: http://dx.doi.org/10.1016/S1074-5521(01)00025-4 | [X] - CAPLUS, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 121:34956, XP002222761 [X] 1-3,8-17 * abstract * | [ ] - TIMOTHY M. WILSON ET AL, "3-[4-(1,2-Diphenylbut-1-enyl)phenyl]acrylic Acid: A Non-Steroidal Estrogen with Functional Selectivity for Bone over Uterus in Rats", J.MED.CHEM., (1994), vol. 37, no. 11, pages 1550 - 1552, XP002091552 DOI: http://dx.doi.org/10.1021/jm00037a002 |